Status:
RECRUITING
Study on the Contribution of the Genetic Tumor Profile Obtained by Circulating Tumor DNA Analysis in the Multidisciplinary Molecular Biology Meeting of Eastern PACA
Lead Sponsor:
Centre Antoine Lacassagne
Conditions:
Neoplasm Malignant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will evaluate the diagnostic performance of liquid biopsy for identifying molecular abnormalities among patients managed by the Multidisciplinary Molecular Biology Meeting. The gold standar...
Eligibility Criteria
Inclusion
- Over 18 years old.
- Advanced-stage malignant solid tumor managed in a non-curative context.
- Patient eligible for Multidisciplinary molecular biology meeting with available archived tumor material (frozen or FFPE block, less than 5 years old) or a biopsiable tumor lesion.
- Performance status of 0 or 1.
- Patient able to read, write, and understand the French language.
- Patient has read the information sheet and signed the informed consent.
- Patient has social security coverage.
Exclusion
- Previous or concurrent cancer diagnosed or treated within the last 5 years, except for in situ carcinoma of the cervix, basal cell or squamous cell carcinoma of the skin, and adequately treated in situ carcinoma of the bladder.
- Severe or uncontrolled systemic disease.
- Any condition which, in the investigator's judgment (geographical, social, or psychological factors, etc.), makes the patient unable to comply with study follow-up and procedures.
- Patient considered a vulnerable person; vulnerable persons are defined in Articles L1121-5 to L1121-8:
- Pregnant women, women in labor, and breastfeeding mothers,
- Persons deprived of liberty by judicial or administrative decision, individuals hospitalized without consent under Articles L. 3212-1 and L. 3213-1 who do not fall under the provisions of Article L. 1121-8,
- Persons admitted to a healthcare or social institution for reasons other than research,
- Adults unable to give their consent.
Key Trial Info
Start Date :
March 3 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 3 2027
Estimated Enrollment :
238 Patients enrolled
Trial Details
Trial ID
NCT06606366
Start Date
March 3 2025
End Date
June 3 2027
Last Update
April 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Antoine Lacassagne
Nice, France, 06189